Status:
UNKNOWN
Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Popliteal Nerve Block
Foot Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
With the increasing rise of outpatient surgery in orthopaedic procedures, the management of immediate postoperative pain has been a major topic investigated, with the use of a peripheral nerve block i...
Eligibility Criteria
Inclusion
- All patients undergoing foot and ankle surgeries under the care of Dr. Steven Raikin with continuous popliteal blocks at Riverview Surgical Center will be considered for enrollment.
Exclusion
- Patients who present with a) known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type,
- Existing use of narcotics,
- Pregnant women,
- Individuals under the age of 18
- Procedures involving any other forms of anesthesia other than general anesthesia with a continuous popliteal nerve block.
Key Trial Info
Start Date :
August 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04872322
Start Date
August 31 2017
End Date
December 31 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107